Resveratrol prevents Drp1‐mediated mitochondrial fission in the diabetic kidney through the PDE4D / PKA pathway
Phytotherapy Research · 2023
DOI: 10.1002/ptr.8004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2023. Verfasst von Xia Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
To explore the role of PDE4D in diabetic nephropathy (DN) and investigate whether resveratrol protects against DN via inhibiting PDE4D. Diabetic db/db mouse and glomerular mesangial cell line (GMCs) were used to investigate the role of PDE4D and the protective effect of resveratrol on renal fibrosis under high glucose (HG) environment. Resveratrol alleviated the progress of DN via inhibiting mitochondrial fragmentation and restoring the expression of PDE4D, PKA, phosphorylated Drp1‐Ser637 and Drp1 in kidney of db/db mice. In HG‐exposed GMCs, resveratrol treatment decreased the expression of PDE4D, increased PKA level, and inhibited Drp1‐mediated mitochondrial fission. In contrast, PDE4D over‐expression blunted the inhibitory effects of resveratrol on Drp1 expression and mitochondrial fission. Moreover, PKA inhibitor H89 blunted the effects of resveratrol on phosphorylated Drp1‐Ser637 expression and mitochondrial fission in HG‐treated GMCs. Inhibition of mitochondrial fission with Drp1 inhibitor Mdivi‐1 alleviated mitochondrial dysfunction in GMCs under HG. These findings indicate PDE4D plays an important role in the process of DN. Resveratrol attenuates the development of DN by preventing mitochondrial fission through inhibiting PDE4D, which regulates the expression of phosphorylated Drp1‐Ser637 directly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China.
ORCID-Profile: Xia Zhu, Xiao-Xing Yin
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhu, X., Deng, Z., Cao, Y., Zhou, Z., Sun, W., Liu, C., Fan, S., & Yin, X. X. (2023). Resveratrol prevents Drp1‐mediated mitochondrial fission in the diabetic kidney through the PDE4D / PKA pathway. Phytotherapy Research. https://doi.org/10.1002/ptr.8004
Vancouver
Zhu X, Deng Z, Cao Y, Zhou Z, Sun W, Liu C, et al. Resveratrol prevents Drp1‐mediated mitochondrial fission in the diabetic kidney through the PDE4D / PKA pathway. Phytotherapy Research. 2023. doi:10.1002/ptr.8004
BibTeX
@article{Zhu2023,
author = {Zhu, Xia and Deng, Zongli and Cao, Yanjuan and Zhou, Zihui and Sun, Wen and Liu, Chang and Fan, Siwen and Yin, Xiao-Xing},
title = {Resveratrol prevents Drp1‐mediated mitochondrial fission in the diabetic kidney through the PDE4D / PKA pathway},
journal = {Phytotherapy Research},
year = {2023},
doi = {10.1002/ptr.8004}
}
EUVIMED